Letter: Reining in the cost of prescription drugs
A major driver of the skyrocketing costs of health care in America is the cost of prescription drugs, costs that year after year are at least two or three times the rate of inflation. Today American citizens pay up to four times more than that which citizens of many other countries pay for the very same prescription.
We should be asking our congressional delegation in Washington, D.C., what the status is of the plan to have the secretary of Health and Human Services negotiate with the prescription drug manufacturers for lower prices to help millions of Medicare beneficiaries. Reportedly, the federal savings is projected to range between $230 billion and $541 billion over the next decade.
As AARP has pointed out, the need for prescription drugs increases as people age and become greater risks for chronic illnesses. Such plays a part in the fact that nationally Medicare beneficiaries spend an average of nearly 30 percent of their income on health care costs.
After all, doesn’t negotiating make good business sense?